These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2336066)

  • 1. Methods for assessing positive and negative symptoms.
    Andreasen NC
    Mod Probl Pharmacopsychiatry; 1990; 24():73-88. PubMed ID: 2336066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative symptoms in schizophrenia: avolition and Occam's razor.
    Foussias G; Remington G
    Schizophr Bull; 2010 Mar; 36(2):359-69. PubMed ID: 18644851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.
    Messinger JW; Trémeau F; Antonius D; Mendelsohn E; Prudent V; Stanford AD; Malaspina D
    Clin Psychol Rev; 2011 Feb; 31(1):161-8. PubMed ID: 20889248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors and symptom severity spectrum in adult schizophrenia: Potential insights for improved management and adequate care.
    Iliuta FP; Manea MC; Teodorescu A; Lacau RM; Manea M; Mares AM; Varlam CI; Ciobanu CA; Ciobanu AM
    Biomed Rep; 2024 Sep; 21(3):132. PubMed ID: 39114301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Lieberman Community Return Program on Reducing Positive and Negative Symptoms and Improving Social Skills in Patients with Schizophrenia.
    Emami M; Kheirabadi G; Fallahi M
    Adv Biomed Res; 2023; 12():146. PubMed ID: 37564452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Assessment of Five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used Symptoms Rating Scales in Schizophrenia and Comparison to Newer Scales (CAINS, BNSS).
    Kumari S; Malik M; Florival C; Manalai P; Sonje S
    J Addict Res Ther; 2017; 8(3):. PubMed ID: 29430333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative symptoms in the psychoses. Re-analysis of published SAPS and SANS global ratings.
    Klimidis S; Stuart GW; Minas IH; Copolov DL; Singh BS
    Schizophr Res; 1993 Mar; 9(1):11-8. PubMed ID: 8461266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Computational Model of Non-optimal Suspiciousness in the Minnesota Trust Game.
    Kazinka R; Vilares I; MacDonald AW
    Comput Psychiatr; 2022; 6(1):60-78. PubMed ID: 38774782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of the Relationship Between C-Reactive Protein Levels and Cognitive Functions in Patients with Schizophrenia, First-Episode Psychosis, and Healthy Controls.
    Demir N; Yıldırım O
    Psychiatry Clin Psychopharmacol; 2022 Dec; 32(4):274-284. PubMed ID: 38764885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the neural correlates of schizophrenia with positive and negative formal thought disorder in patients with schizophrenia in the ENIGMA dataset.
    Sharkey RJ; Bacon C; Peterson Z; Rootes-Murdy K; Salvador R; Pomarol-Clotet E; Karuk A; Homan P; Ji E; Omlor W; Homan S; Georgiadis F; Kaiser S; Kirschner M; Ehrlich S; Dannlowski U; Grotegerd D; Goltermann J; Meinert S; Kircher T; Stein F; Brosch K; Krug A; Nenadic I; Sim K; Spalletta G; Banaj N; Sponheim SR; Demro C; Ramsay IS; King M; Quidé Y; Green MJ; Nguyen D; Preda A; Calhoun V; Turner J; van Erp T; Nickl-Jockschat T
    Mol Psychiatry; 2024 Oct; 29(10):3086-3096. PubMed ID: 38671214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and Reliability Study of Turkish Version of Clinical Assessment Interview for Negative Symptoms (CAINS).
    Vayisoğlu S; Karahan S; Gürel ŞC; Yağcioğlu AEA
    Noro Psikiyatr Ars; 2024; 61(1):59-65. PubMed ID: 38496217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Psychotic and Depressive Symptoms in Methamphetamine Users.
    Karabulut S
    Iran J Psychiatry; 2024 Jan; 19(1):1-10. PubMed ID: 38420276
    [No Abstract]   [Full Text] [Related]  

  • 13. Tract-based analyses of white matter in schizophrenia, bipolar disorder, aging, and dementia using high spatial and directional resolution diffusion imaging: a pilot study.
    Mamah D; Chen S; Shimony JS; Harms MP
    Front Psychiatry; 2024; 15():1240502. PubMed ID: 38362028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of consciousness depends on insight in OCD and on positive symptoms in schizophrenia.
    Tumkaya S; Yücens B; Gündüz M; Maheu M; Berkovitch L
    bioRxiv; 2024 Jan; ():. PubMed ID: 38293050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Dynamic Laterality Based on Functional Subnetworks in Patients with Bipolar Disorder.
    Li D; Hao J; Hao J; Cui X; Niu Y; Xiang J; Wang B
    Brain Sci; 2023 Nov; 13(12):. PubMed ID: 38137094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural Correlates of Positive and Negative Formal Thought Disorder in Individuals with Schizophrenia: An ENIGMA Schizophrenia Working Group Study.
    Nickl-Jockschat T; Sharkey R; Bacon C; Peterson Z; Rootes-Murdy K; Salvador R; Pomarol E; Karuk A; Homan P; Ji E; Omlor W; Homan S; Georgiadis F; Kaiser S; Kirschner M; Ehrlich S; Dannlowski U; Grotegerd D; Goltermann J; Meinert S; Kircher T; Stein F; Brosch K; Krug A; Nenadic I; Sim K; Piras F; Banaj N; Sponheim S; Demro C; Ramsay I; King M; Quidé Y; Green M; Nguyen D; Preda A; Calhoun V; Turner J; van Erp T; Spalletta G
    Res Sq; 2023 Sep; ():. PubMed ID: 37841855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of Gut Microbiome in Patients With Schizophrenia Indicates Links Between Bacterial Tyrosine Biosynthesis and Cognitive Dysfunction.
    Thirion F; Speyer H; Hansen TH; Nielsen T; Fan Y; Le Chatelier E; Fromentin S; Berland M; Plaza Oñate F; Pons N; Galleron N; Levenez F; Markó L; Birkner T; Jørgensen T; Forslund SK; Vestergaard H; Hansen T; Nordentoft M; Mors O; Benros ME; Pedersen O; Ehrlich SD
    Biol Psychiatry Glob Open Sci; 2023 Apr; 3(2):283-291. PubMed ID: 37124355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory neuronal cells as a promising tool to realize the "druggable genome" approach for drug discovery in neuropsychiatric disorders.
    Mihaljevic M; Lam M; Ayala-Grosso C; Davis-Batt F; Schretlen DJ; Ishizuka K; Yang K; Sawa A
    Front Neurosci; 2022; 16():1081124. PubMed ID: 36967982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the CYP2D6 Genotype Associated with Antipsychotic-Induced Weight Gain?
    Jürgens G; Kaas-Hansen BS; Nordentoft M; Werge T; Andersen SE
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral inflammation levels associated with degree of advanced brain aging in schizophrenia.
    Klaus F; Nguyen TT; Thomas ML; Liou SC; Soontornniyomkij B; Mitchell K; Daly R; Sutherland AN; Jeste DV; Eyler LT
    Front Psychiatry; 2022; 13():966439. PubMed ID: 36032250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.